​

Creative Medical Technology Stock (NASDAQ:CELZ)

RevenueOwnershipFinancialsChart

Previous Close

$3.41

52W Range

$1.69 - $6.90

50D Avg

$3.01

200D Avg

$2.80

Market Cap

$8.88M

Avg Vol (3M)

$147.50K

Beta

5.34

Div Yield

-

CELZ Company Profile

Creative Medical Technology Holdings, Inc., a biotechnology company, focuses on immunology, urology, orthopedics, and neurology using adult stem cell treatments. The company offers CaverStem to treat erectile dysfunction; FemCelz for the treatment of loss of genital sensitivity and dryness; StemSpine to treat chronic lower back pain; ImmCelz for the treatment of stroke patients; and OvaStem for treatment of female infertility. Creative Medical Technology Holdings, Inc. is based in Phoenix, Arizona.

Show More

Industry

Biotechnology

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

4

IPO Date

Nov 06, 2015

Website

CELZ Performance

CELZ Financial Summary

Dec 24Dec 23Dec 22
Revenue$11.00K$9.00K$88.60K
Operating Income$-5.63M$-5.62M$-10.24M
Net Income$-5.49M$-5.29M$-10.04M
EBITDA$-5.63M$-5.53M$-10.15M
Basic EPS$-3.71$-3.76$-9.19
Diluted EPS$-3.71$-3.76$-9.19

Fiscal year ends in Dec 24 | Currency in USD

Peer Comparison

TickerCompany
APMAptorum Group Limited
LSBLakeShore Biopharma Co., Ltd
SBFMSunshine Biopharma, Inc.
AREBAmerican Rebel Holdings, Inc.
AGRIAgriFORCE Growing Systems Ltd.
ENSCEnsysce Biosciences, Inc.